Artis Ventures is a pioneering venture capital firm dedicated to investing in the convergence of technology, biology, and health—collectively termed "Tech Bio+Health." As the first fund globally to deploy capital in this transformative sector, Artis Ventures focuses on companies that leverage data, software, AI, machine learning, and deep learning to revolutionize human health and well-being. The firm coined and trademarked the term "TechBio" to signify a new era in medicine, where advancements in sequencing, computing, data management, and synthetic biology are reshaping healthcare approaches. With a global perspective, Artis Ventures aims to invest in scalable medical technologies that can improve health outcomes and cure diseases worldwide.

Their portfolio includes data-driven life sciences companies addressing everyday health challenges through engineering-first approaches, personalized therapeutics, and efficient drug discovery.